Oral Levodopa Formulation Does Not Affect Progression of Parkinson Disease

Conclusions We found no difference in symptom progression rate in patients taking IR, CR, or CLE. This clinical observation supports pharmacokinetic studies demonstrating that none of these oral levodopa formulations achieve continuous dopamine stimulation.
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research